Jochen Wilke
Impact in
- Reproductive Medicine top 10%
- Ovarian cancer diagnosis and treatment
- Hematology top 10%
- Hemophilia Treatment and Research
- Blood Coagulation and Thrombosis Mechanisms
- Platelet Disorders and Treatments
Papers in
-
- Renal cell carcinoma treatment 4
- Lung Cancer Treatments and Mutations 4
- Ferroptosis and cancer prognosis 2
- Oncology 10
- Cancer Immunotherapy and Biomarkers 5
- Co-authors
- William L. Nichols (2 shared papers)Gerald S. Gilchrist (2 shared papers)David Dingli (1 shared paper)D A Gastineau (1 shared paper)John A. Heit (1 shared paper)Rajiv K. Pruthi (1 shared paper)Reinhard Andreesen (5 shared papers)T. Suedhoff (4 shared papers)
- Journals
- Journal of Clinical Oncology (4 papers)Haemophilia (3 papers)HemaSphere (2 papers)Stem Cells (1 paper)Medical Oncology (1 paper)
- Partner nations
- GermanyUnited StatesSwitzerland
In The Last Decade
Jochen Wilke
17 papers receiving 253 citations
Peers
Comparison fields: 5 of 45
- Reproductive Medicine 73
- Hematology 77
- Internal Medicine 20
- Oncology 98
- Obstetrics and Gynecology 24
Countries citing papers authored by Jochen Wilke
This map shows the geographic impact of Jochen Wilke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jochen Wilke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jochen Wilke more than expected).
Fields of papers citing papers by Jochen Wilke
This network shows the impact of papers produced by Jochen Wilke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jochen Wilke. The network helps show where Jochen Wilke may publish in the future.
Co-authors
The 25 scholars most cited alongside Jochen Wilke, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 76 | |
| 2 | 2000 | 39 | |
| 3 | 2002 | 36 | |
| 4 | 2011 | 25 | |
| 5 | 2015 | 19 | |
| 6 | C-reactive Protein in Patients with Metastatic Clear Cell Renal Carcinoma: An Important Biomarker for Tumor-associated Inflammation. | 2007 | 16 |
| 7 | 2021 | 9 | |
| 8 | Cetuximab with irinotecan/NA-FA/5-FU as first-line treatment in advanced gastric cancer: Preliminary results of a non-randomised multi-centre AIO phase II study | 2008 | 8 |
| 9 | 2006 | 7 | |
| 10 | 2001 | 7 | |
| 11 | 2007 | 6 | |
| 12 | 2021 | 5 | |
| 13 | 2006 | 4 | |
| 14 | 2019 | 3 | |
| 15 | 2021 | 3 | |
| 16 | 2025 | 1 | |
| 17 | 2007 | 1 | |
| 18 | 2025 | 0 | |
| 19 | 2024 | 0 | |
| 20 | 2006 | 0 |
About Jochen Wilke
Jochen Wilke is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Surgery, Molecular Biology and Genetics, having authored 21 papers that have together received 265 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (5 papers), Renal cell carcinoma treatment (4 papers), Lung Cancer Treatments and Mutations (4 papers), Hemophilia Treatment and Research (3 papers), Chronic Lymphocytic Leukemia Research (3 papers), Cancer, Lipids, and Metabolism (2 papers), Immunodeficiency and Autoimmune Disorders (2 papers) and Ferroptosis and cancer prognosis (2 papers). The work is most often cited by research in Reproductive Medicine (73 citations), Hematology (77 citations), Internal Medicine (20 citations), Oncology (98 citations) and Obstetrics and Gynecology (24 citations). Jochen Wilke has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include William L. Nichols, Gerald S. Gilchrist, David Dingli, D A Gastineau, John A. Heit, Rajiv K. Pruthi, Reinhard Andreesen, T. Suedhoff, K. Bross and Albrecht Reichle. Their work appears in journals such as Journal of Clinical Oncology, Haemophilia, HemaSphere, Stem Cells and Medical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.